Buprenorphine + Naloxone Sublingual Films/Tablets Suppliers & Bulk Manufacturers

Available Forms: Sublingual Films/Tablets

Available Strengths: 2 mg buprenorphine / 0.5 mg naloxone, 8 mg / 2 mg

Reference Brands: Suboxone(US)

Category: Analgesic

Buprenorphine + Naloxone Sublingual Films/Tablets is available in Sublingual Films/Tablets and strengths such as 2 mg buprenorphine / 0.5 mg naloxone, 8 mg / 2 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Buprenorphine + Naloxone Sublingual Films/Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Buprenorphine + Naloxone Sublingual Films/Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Buprenorphine + Naloxone sublingual films and tablets are approved in the EU and US primarily for opioid dependence treatment, with some off-label use for pain. In the US, brands like Suboxone are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the EU, approval by EMA involves comprehensive dossiers, clinical data, and pharmacovigilance plans. Due to abuse potential, strict prescribing controls and monitoring are enforced. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for buprenorphine + naloxone formulations, ensuring adherence to European and US standards for safe, effective opioid dependence management and pain therapy.